Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
about
A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnesMicrobiome precision editing: Using PEG as a selective fermentation initiator against methicillin-resistant Staphylococcus aureus.New perspectives in the management of Pseudomonas aeruginosa infections.
P2860
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@ast
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en-gb
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@nl
type
label
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@ast
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en-gb
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@nl
prefLabel
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@ast
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en-gb
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@nl
P2093
P2860
P50
P3181
P1476
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
@en
P2093
Alan R Smyth
Douglas L Forrester
Matthew N Hurley
P2860
P304
P3181
P356
10.1002/14651858.CD008037.PUB3
P577
2013-06-05T00:00:00Z